In this regard, metformin, the first-line oral drug for type-2 diabetes, has been shown to enhance C. elegans tolerance to pathogen infection by acting through pmk-1, the main actor of the nematode p38/MAPK signaling pathway [52]. Here, MAPK14 is linked to infection.